{"name": "levobetaxolol", "category": "drug", "content": "Levobetaxolol is a drug used to lower the pressure in the eye in treating conditions such as glaucoma.  It is marketed as a 0.25 or 0.5% ophthalmic solution of levobetaxolol hydrochloride under the trade name Betaxon.  Levobetaxolol is a beta-adrenergic receptor inhibitor (beta blocker).   == Indications == It is indicated for intraocular pressure reduction in patients with open-angle glaucoma or ocular hypertension.   == Effect == Levobetaxolol inhibits the beta-1-adrenergic receptor. When applied topically, it reduces intra-ocular pressure (IOP) by 16-23% depending on time of day and the individual. It also has neuroprotective effects. Levobetaxolol has fewer cardiovascular side effects than other beta blockers.   == Contraindications and side effects == Levobetaxolol should not be used by people who have sinus bradycardia, atrioventricular block, cardiogenic shock, or overt cardiac failure. The drug has been associated with bradycardia and hypertension.   == History == Levobetaxolol was developed in the 1980s. It was FDA approved in 2000.   == References =="}